Virtus Fund Advisers’s Edwards Lifesciences EW Stock Holding History

Virtus Fund Advisers’s Portfolio EW Stock Details EW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q4	$10.3M	Sell	274,995 -88,347	-24%	-$3.24M	0.1%	183
2017 Q3	$13.2M	Sell	363,342 -105,339	-22%	-$4.02M	0.13%	177
2017 Q2	$18.5M	Sell	468,681 -54,438	-10%	-$1.99M	0.18%	178
2017 Q1	$16.4M	Sell	523,119 -4,974	-0.9%	-$156K	0.15%	181
2016 Q4	$16.5M	Sell	528,093 -18,552	-3%	-$601K	0.14%	177
2016 Q3	$22M	Buy	546,645 +23,988	+5%	+$903K	0.19%	157
2016 Q2	$17.2M	Buy	522,657 +315,438	+152%	+$10.8M	0.15%	170
2016 Q1	$6.09M	Buy	+207,219	New	+$5.72M	0.05%	239
2015 Q1	–	Sell	-738	Closed	-$16K	–	939
2014 Q4	$16K	Hold	738	–	–	﹤0.01%	971
2014 Q3	$13K	Sell	738 -5,730	-89%	-$90.5K	﹤0.01%	1020
2014 Q2	$93K	Buy	+6,468	New	+$87.7K	﹤0.01%	1441

Other funds holding EW

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Sands Capital Management Arlington, Virginia $26.9B AUM 34.44% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Virtus Fund Advisers's EW Position: Q4 2017 in Review

Virtus Fund Advisers reduced its Edwards Lifesciences (EW) stake by 24% in Q4 2017, selling an estimated $3.24M and leaving 274,995 shares worth $10.3M. The position accounts for 0.1% of the portfolio, ranked #183.

Virtus Fund Advisers first reported a position in EW in Q2 2014 and has held it in 11 quarters since. The position peaked at $22M in Q3 2016. 773 funds tracked by Wall St. Rank hold EW as of Q4 2017.

Virtus Fund Advisers held 274,995 shares of Edwards Lifesciences worth $10.3M as of Q4 2017.
Virtus Fund Advisers sold 88,347 Edwards Lifesciences shares in Q4 2017, an estimated $3.24M.
Edwards Lifesciences made up 0.1% of Virtus Fund Advisers's portfolio in Q4 2017, its #183 holding.
Virtus Fund Advisers first reported a position in Edwards Lifesciences in Q2 2014 and has held it in 11 quarters since.
Virtus Fund Advisers's Edwards Lifesciences position peaked at $22M in Q3 2016.
773 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q4 2017.

Based on Virtus Fund Advisers's 13F filing for Q4 2017, filed 9 Feb 2018.